United States · FDA National Drug Code directory
Bath and Body Works SPF Tahiti Isle
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62670-6864_38d0d1d3-0655-99b6-e063-6394a90ac92d
- Product NDC
- 62670-6864
- Form
- GEL
- Composition / generic term
- Avobenzone,Homosalate,Octisalate,Octocrylene
- Labeler
- Bath & Body Works, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20250505
- Source listing expiry
- 20261231
Source-listed ingredients
- OCTOCRYLENE — 10 mg/100mg
- AVOBENZONE — 3 mg/100mg
- HOMOSALATE — 10 mg/100mg
- OCTISALATE — 5 mg/100mg
These values do not establish equivalence or a dose recommendation.
Packages
- 103 mg in 1 BOTTLE (62670-6864-0) · 62670-6864-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →